Breakthrough cancer pain (BTcP) is a sudden, severe flare of pain that occurs despite otherwise controlled, around-the-clock cancer pain treatment. These episodes are rapid in onset, high in intensity, and short-lived—often leaving patients physically and emotionally overwhelmed. While fast-acting opioids such as morphine or fentanyl are traditionally used for these episodes, Aspadol ER 200mg (tapentadol extended-release) represents a different strategy. Rather than acting as a quick “rescue” medication, it is designed to stabilize baseline pain control, which can reduce the frequency and severity of breakthrough episodes when used appropriately. https://safe4cure.com/product/aspadol-er-200-mg/